Showing posts with label international market. Show all posts
Showing posts with label international market. Show all posts

Dec 29, 2009

Emerging Markets Keep Soaring Past Their Doubters

Published: December 29, 2009

NEW DELHI — This was a lost decade for the American stock market. But for much of developing world, it was the Roaring ’00s — a period of soaring markets and breakneck investment that left even some bulls wondering if the good times can last.

Rajanish Kakade/Associated Press

Onlookers reacted to the stock display at the Bombay Stock Exchange building last May, when the market rallied following the decisive victory of the Congress Party.

While the broad American market lost about a fifth of its value in the last 10 years, emerging markets like Brazil, Russia, China and India powered ahead with gains in the double or even triple digits.

The numbers are staggering. On the Ukraine’s PFTS Stock Exchange — a Wild East of investing that did not even exist until 1997 — shares soared more than 1,350 percent over the last decade. In Peru, stocks jumped more than 660 percent. Here in India, the Sensex index leaped more than 240 percent.

The {{w|Potential superpowers}} or {{w|BRIC}} ...Image via Wikipedia

To believers, those heady gains underscore profound shifts taking place in the global economy, where investment dollars, euros and yen whiz across borders and time zones with the stroke of a computer key. As many Americans wait for an economic recovery, money is pouring into the fast-growing economies of Asia and Latin America, as well as into oil-rich Russia and the former Soviet bloc.

“What we’re living through now is something of epic proportions,” said Allan Conway, the head of emerging markets equities at Schroders, the big money management company in London. He likened the economic rise of nations like Brazil, Russia, India and China — the so-called BRIC countries — to that of postwar Japan.

Amid all this euphoria, even some longtime bulls wonder if investors are getting a bit carried away. Emerging markets have a history of giddy booms and crushing busts dating back to the 19th century. They collapsed spectacularly in 1997, as a chain reaction of currency devaluations, bankruptcies and recessions rocked East Asia. In 1998, the Russian market plunged more than 80 percent after the country defaulted on its debts.

Thematic map with the estimates of the countri...Image via Wikipedia

More recently, emerging markets tanked with the rest of the world in 2008, after shell-shocked money managers pulled cash from anywhere that seemed risky. But they were a bright spot in 2009 — the MSCI Emerging Markets index increased 73 percent in 2009, compared with a 25 percent jump in the S.& P. 500 index.

Despite 2009’s gains, few predict a major setback today. Since the 1998 debacle, some developing countries have cleaned up their acts, balancing their budgets and improving their trade balances. As their economies grow, domestic investors have become big supporters of these countries’ stock markets. With interest rates low around the world, companies based in emerging markets, like their counterparts in the developed world, enjoy access to cheap money. High commodities prices have buoyed stock and bond markets in nations that are big exporters of commodities.

But the recent travails of Dubai, where a debt-driven bubble economy is now bursting, provide a powerful reminder that in up-and-coming economies, what goes up can come down — and fast. That these markets have gained so much, so quickly — with some white-knuckled drops along the way — gives some investment professionals pause.

Municipality of Shanghai · 上海市Image via Wikipedia

Mark Mobius, one of the deans of emerging market investing, said that while developing markets still have room to run, the first half of 2010 could be bumpy.

“We continue to see upside, but with substantial corrections along the way, which could be as much as 20 percent,” said Mr. Mobius, the executive chairman of Franklin Templeton Investments, which is based in San Mateo, Calif.

Some market specialists worry that asset bubbles akin to the one that inflated and burst in the American housing market might be growing in places like China and Hong Kong. Others fret over the risks posed by volatile commodities prices, as well as over the inevitable end of this period of ultralow interest rates.

Leon Goldfeld, the chief investment officer for HSBC Global Asset Management in Hong Kong, told reporters this month that HSBC had cut its exposure to Asian equities, anticipating a 10 percent to 15 percent decline in early 2010. After that, Mr. Goldfeld said, Asian stocks would represent a “good buying opportunity.”

As long-term investments go, emerging markets seem to have a lot going for them. On average, developing countries have less sovereign, corporate and household debt than developed countries. Their economies are also growing faster than industrialized ones. Merrill Lynch predicts that emerging market economies will grow 6.3 percent next year, while the global economy expands by 4.4 percent.

Emerging markets are eclipsing their developed peers in other ways as well. Imports to the BRIC nations are likely to surpass imports to the United States for the first time ever in 2009, according to Morgan Stanley.

For the moment, the developing world is the engine of global growth. Emerging markets accounted for virtually all of the year’s growth in global output, because developed economies shrank or were flat. Even if developed countries recover completely in 2010, emerging economies will account for 70 to 75 percent of the growth in global output “for the foreseeable future,” said Mr. Conway of Schroders.

Developing nations are also assuming a bigger role in the world economy. Morgan Stanley predicts that developing countries, including those in the Middle East, will account for 36 percent of total global gross domestic product in 2010, up from 21 percent in 1999.

All of this is a big lure to investors. Funds focused on equities in emerging markets attracted a record $75.4 billion this year, far surpassing their previous high of $54 billion in 2007, according to EPFR Global, which tracks fund flows.

Even after that influx, emerging markets still account for only a small fraction of investment portfolios in United States and Europe, the world’s money management centers. Less than 3 percent of assets managed by United States fund managers are invested in emerging markets. That number could double in the next five years, some investment experts say.

Even normally conservative investors might be tempted to jump into emerging markets, given the sluggish outlook in the United States and Europe. After a dismal decade for the American stock market, markets in the developing countries might seem attractive.

“Investors are starting to look at this asset class and realize that it is a pretty safe place,” said Kevin Daly, who manages $1.7 billion in emerging market debt at Aberdeen Asset Management.

Despite their volatile history, emerging markets strike some money managers as relatively secure places to invest. Of course, such hopes have been dashed before.

Reblog this post [with Zemanta]

Jul 30, 2009

Organ Trafficking Fueled by Worldwide Market

They won’t look the doctor in the eye, and their stories have holes — after all, how often does someone offer a spare kidney to a third cousin he just met?

Eventually, many would-be live-organ donors simply disappear; at one hospital, Hackensack University Medical Center, more than half drop out of the transplant process after initial meetings with doctors.

Dr. Michael Shapiro, the chief surgeon of the hospital’s transplant unit, said he suspects that many of those people are looking to be paid for their body parts, but fear getting caught.

“Sometimes, you have to sit down with the donor and say: ‘It’s illegal to buy or sell organs. You know that, right?’ ” Dr. Shapiro said.

Among the 44 people arrested last week in one of the most sweeping bribery and money-laundering investigations in New Jersey history, one stood out: Levy-Izhak Rosenbaum, a Brooklyn businessman who was accused of trying to broker the purchase of a kidney for $160,000.

Though most developed countries, including the United States, ban organ sales, there is an international market for transplantable organs: a shady world of unscrupulous doctors, concocted relationships and hotels used as recovery rooms.

The World Health Organization estimates that about 10 percent of the 63,000 kidneys transplanted worldwide each year from living donors have been bought illegally. Lungs, pieces of livers and corneas also command a price.

Last year, the authorities in India said they had broken up a ring involving doctors, nurses, paramedics and hospitals that had performed 500 illegal transplants of organs to rich Indians and foreigners. Most of the donors were poor laborers who were paid up to $2,500 for a kidney. Some were forced to give up organs at gunpoint.

Federal authorities say Mr. Rosenbaum told an undercover investigator that he had been brokering the sale of organs for 10 years and had been involved with “quite a lot” of transplants. According to the criminal complaint, Mr. Rosenbaum was approached by the same government witness who persuaded a number of New Jersey officials, including the mayor of Hoboken, to accept bribes, and who snared several rabbis in a money-laundering operation.

In Mr. Rosenbaum’s case, the witness, believed to be Solomon Dwek, a New Jersey developer arrested on bank fraud charges in 2006, pretended to a businessman whose secretary was looking for a kidney for her uncle. An undercover agent posed as the secretary.

“Let me explain to you one thing,” Mr. Rosenbaum told her, according to the complaint. “It’s illegal to buy or sell organs.”

Mr. Rosenbaum later received $10,000 as a down payment for delivery of a willing organ donor, the authorities said. The total cost, as agreed upon, would eventually have been $160,000.

Mr. Rosenbaum spoke of the strengths and weaknesses of hospitals’ screening procedures. He told the agent that the donor would come from Israel, that he would be young and healthy, and that once he was in the United States, the donor and the recipient would need to make up a story to tell hospital officials.

The donor could not pretend to be a relative, not even a third cousin — the relationship Dr. Shapiro said he sometimes hears — as that would be too easily disproved, Mr. Rosenbaum said. Instead, he said, they should choose a different story, saying, perhaps, that they were neighbors, friends from synagogue or business acquaintances. “Could be friends from the community, could be friends of, of, of his children,” Mr. Rosenbaum said, according to the complaint.

Ronald Kleinberg, Mr. Rosenbaum’s lawyer, said he would not comment because he had not yet obtained all the facts in the case.

Doctors have become more aware of organ-selling schemes, but many still feel powerless.

“When you have the suspicion the donor is doing this for the wrong reasons, the question is — what do we do?” Dr. Shapiro said. “I don’t have a detective on retainer. I don’t have a polygraph. We’re pretty good at surgery, but part of the medical school curriculum is not interrogation techniques.”

Some doctors may feel that the Hippocratic oath prevents them from turning away a sick patient with an organ ready to be transplanted. Others may simply be tempted by the money involved.

“There’s this perverse motivation for me to say yes. It takes a really honest person to say, ‘I’m not going to do this, even if it will reduce my numbers,’ ” Dr. Shapiro said.

To those needing a kidney who are dependent on dialysis machines, the wait for a new organ can seem daunting.

The length of time generally depends on the patient’s condition and blood type; most organ transplants in the United States are based on a waiting-list system formed by Congress in 1984 and run by the United Network for Organ Sharing.

In New York, the average wait for a new kidney is nine years.

For those who cannot or no longer want to wait for a kidney, the only other legal option is to find someone willing to donate an organ of their own free will, and free of charge, usually a relative or friend.

While many doctors and academics sympathize with those who in effect want to buy a longer life, the general concept behind the ban on paying for organs is that society’s poorest people should not be enticed to sell their own bodies and that its richest should not be able to buy their way out of the existing system.

Dr. Luc Noel, the coordinator of clinical procedures in the Department of Essential Health Technologies at the World Health Organization, said the organization has been wrestling for years with whether or how to legalize organ sales.

“The truth is, it’s people in poor countries who choose between selling a kidney or a child,” Dr. Noel said. “It’s not caricature. It’s reality.”

Sheila M. Rothman, a professor of public health at Columbia University who studies living organ transplantation, said it has opened a Pandora’s box of questions no government has been able to answer fairly.

“In principle there’s nothing wrong with selling an organ, but if you try to get someone to articulate it and what it means, nobody can explain an equitable way to do it,” Dr. Rothman said.

Some doctors, however, say that since demand is so high, and waiting times for organs from cadavers so long, organ sales should be legalized, but tightly regulated.

“It has to have a built-in system for checking the individuals’ motivations to be sure they’re not being coerced. There should be a fair and established price,” said Dr. Eli A. Friedman, a distinguished teaching professor and the chief of the Division of Nephrology at the SUNY Downstate Medical Center in Brooklyn.

Dr. Friedman said brokers wanting to find people seeking kidneys had tried turning to him.

“I’ve had kidney agents come into my office and offer to give me $5,000 for every person who I referred to them,” he said.